-
EP3573968
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3573968
| EP3573968 - NRF2 ACTIVATOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.08.2021 Database last updated on 16.11.2024 | |
| Former | Grant of patent is intended Status updated on 29.11.2020 | ||
| Former | Request for examination was made Status updated on 02.11.2020 | ||
| Former | Grant of patent is intended Status updated on 23.06.2020 | ||
| Former | Request for examination was made Status updated on 01.11.2019 | ||
| Former | The international publication has been made Status updated on 04.08.2018 | ||
| Former | unknown Status updated on 27.02.2018 | Most recent event Tooltip | 20.08.2021 | Application deemed to be withdrawn | published on 22.09.2021 [2021/38] | Applicant(s) | For all designated states Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 / US | [2019/49] | Inventor(s) | 01 /
CAPACCI, Andrew, George 77 Trowbridge Street Apt. 72 Cambridge MA 02138 / US | 02 /
DECHANTSREITER, Michael 45 Hopedale Street Allston MA 02134 / US | 03 /
ENYEDY, Istvan 15 Lyman Road Milton MA 02186 / US | 04 /
JONES, John, H. 7 Stanley Drive Framingham MA 01701 / US | 05 /
LIN, Edward, Yin-Shiang 22 Pilgrim Road Ashland MA 01721 / US | 06 /
LUCAS, Brian, Stuart 4 Brantwood Road Arlington MA 02476 / US | 07 /
MA, Bin 211 Wachusett Avenue Arlington MA 02476 / US | [2019/49] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [N/P] |
| Former [2019/49] | HGF Limited 4th Floor Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | Application number, filing date | 18705236.0 | 29.01.2018 | [2019/49] | WO2018US15738 | Priority number, date | US201762452120P | 30.01.2017 Original published format: US 201762452120 P | [2019/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018140876 | Date: | 02.08.2018 | Language: | EN | [2018/31] | Type: | A1 Application with search report | No.: | EP3573968 | Date: | 04.12.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.08.2018 takes the place of the publication of the European patent application. | [2019/49] | Search report(s) | International search report - published on: | EP | 02.08.2018 | Classification | IPC: | C07D401/14, C07D401/06, C07D417/14, A61P25/00, A61P7/00, A61K31/472 | [2019/49] | CPC: |
C07D401/06 (EP,US);
A61P25/00 (EP);
A61P7/00 (EP);
C07D215/14 (US);
C07D401/14 (EP,US);
C07D405/14 (US);
C07D413/14 (US);
C07D417/14 (EP,US);
C07D451/02 (US);
C07D471/04 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/49] | Title | German: | NRF2-AKTIVATOR | [2019/49] | English: | NRF2 ACTIVATOR | [2019/49] | French: | ACTIVATEUR DE NRF2 | [2019/49] | Entry into regional phase | 23.08.2019 | National basic fee paid | 23.08.2019 | Designation fee(s) paid | 23.08.2019 | Examination fee paid | Examination procedure | 23.08.2019 | Examination requested [2019/49] | 23.08.2019 | Date on which the examining division has become responsible | 24.03.2020 | Amendment by applicant (claims and/or description) | 24.06.2020 | Communication of intention to grant the patent | 29.10.2020 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 30.11.2020 | Communication of intention to grant the patent | 13.04.2021 | Application deemed to be withdrawn, date of legal effect [2021/38] | 04.05.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2021/38] | Fees paid | Renewal fee | 23.08.2019 | Renewal fee patent year 03 | 13.01.2021 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO02098426 (AVENTIS PHARMA LIMTIED [GB], et al) [A] 1-47* page 28 *; | [A]WO2013067036 (UNIV RUTGERS [US], et al) [A] 1-47 * example - *; | [A] - MEI-YANG XI ET AL, "3-Aroylmethylene-2,3,6,7-tetrahydro-1 H -pyrazino[2,1- a ]isoquinolin-4(11b H )-ones as Potent Nrf2/ARE Inducers in Human Cancer Cells and AOM-DSS Treated Mice", JOURNAL OF MEDICINAL CHEMISTRY, (20131009), vol. 56, no. 20, doi:10.1021/jm400944k, ISSN 0022-2623, pages 7925 - 7938, XP055464543 [A] 1-47 * abstract * DOI: http://dx.doi.org/10.1021/jm400944k | by applicant | CA94538 | US4938949 |